Lean Changeover guidance

newsJul 30, 2018 | Phorum : Drug Substance | News

These two related papers help those involved with the design and organization of product changeover drug substance operations to justify the elimination of elastomer change-outs and reduce other changeovers. Using a science-based risk management approach the guides show how to ensure that value-added work is the sole focus of changeovers and how unnecessary changeover activity can be eliminated, reduced or removed from the facility down time.




Follow BioPhorum

Related tags

Recent releases


Submit a Comment

Your email address will not be published. Required fields are marked *

Share This